TABLE 1

Changes in CBF and V₀ in ACZ Test and Other Parametric Values (Mean ± SD)

Parameter	Patients with CVD (n = 22)
Parameter		Ipsilateral	Contralateral
CBF (mL/min/100 g)
Baseline	36.5 ± 8.1*	40.8 ± 6.8
ACZ	41.5 ± 11.2*^†	54.7 ± 9.5^‡
Change (%)	13.6 ± 20.2*	35.1 ± 17.6
V₀ (mL/100 g)
Baseline	1.73 ± 0.50*	2.11 ± 0.51
ACZ	2.23 ± 0.61*^‡	2.94 ± 0.73^‡
Change (%)	31.8 ± 26.1^§	42.6 ± 30.7
CMRo₂ (mL/min/100 g)	2.71 ± 0.44^§	2.99 ± 0.33
OEF (%)	50.2 ± 7.4^§	47.7 ± 6.2
CBV (mL/100 g)	4.21 ± 0.50^§	3.90 ± 0.49

↵* P < 0.001
↵^§ P < 0.005 comparing between bilateral hemispheres (repeated-measures ANOVA and paired t test).
^† P < 0.005
↵^‡ P < 0.001 comparing before and after ACZ administration (repeated-measures ANOVA and paired t test).
Values are given for regions of bilateral MCAs.